An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli.
The A/H1N1/2009 influenza pandemic made evident the need for faster and higher-yield methods for the production of influenza vaccines. Platforms based on virus culture in mammalian or insect cells are currently under investigation. Alternatively, expression of fragments of the hemagglutinin (HA) pro...
Main Authors: | José M Aguilar-Yáñez, Roberto Portillo-Lara, Gonzalo I Mendoza-Ochoa, Sergio A García-Echauri, Felipe López-Pacheco, David Bulnes-Abundis, Johari Salgado-Gallegos, Itzel M Lara-Mayorga, Yenny Webb-Vargas, Felipe O León-Angel, Ramón E Rivero-Aranda, Yuriana Oropeza-Almazán, Guillermo M Ruiz-Palacios, Manuel I Zertuche-Guerra, Rebecca M DuBois, Stephen W White, Stacey Schultz-Cherry, Charles J Russell, Mario M Alvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-07-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2908544?pdf=render |
Similar Items
-
Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method.
by: Mario M Alvarez, et al.
Published: (2010-04-01) -
Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity.
by: Rebecca M DuBois, et al.
Published: (2011-12-01) -
Role of Mitochondrial ROS for Calcium Alternans in Atrial Myocytes
by: Yuriana Oropeza-Almazán, et al.
Published: (2024-01-01) -
Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine
by: John V. Dzimianski, et al.
Published: (2023-04-01) -
Hemagglutinins of haemophilus paragallinarum Serotype 1 organisms /
by: 271463 Akira Sawata, et al.